Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHA/688617 stock hub

SHA/688617 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688617is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

32.7B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688617

In the news

Latest news · SHA/688617

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.9

P25 17.1P50 24.2P75 37.8

Trailing P/E38

P25 23.5P50 41.3P75 83.2

ROE29.7

P25 -0.9P50 4.1P75 8.8

ROIC48.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688617 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,118
Employees Change	563%
Employees Change Percent	22.04
Enterprise value	CNY 31.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100004C45
Last refreshed	2026-05-10
Market cap	CNY 32.7B
Price	CNY 233
Price currency	CNY
Rev Per Employee	873,550.01x
Sector	Healthcare
Sic	3841
Symbol	sha/688617
Website	https://www.aptmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.65%
EV Earnings	36.31x
EV/EBIT	33.33x
EV/EBITDA	29.69x
EV/FCF	44.82x
EV/Sales	11.56x
FCF yield	2.15%
Forward P/E	29.9x
P/B ratio	10.88x
P/E ratio	37.96x
P/S ratio	12.01x
PE Ratio3 Y	51.22x
PE Ratio5 Y	63.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.68%
EBITDA Margin	38.58%
FCF margin	25.78%
Gross margin	72.48%
Gross Profit	CNY 2B
Gross Profit Growth	25.7%
Gross Profit Growth Q	23.65%
Gross Profit Growth3 Y	28.8%
Gross Profit Growth5 Y	37.5%
Net Income	CNY 866.9M
Net Income Growth	21.05%
Net Income Growth Q	25.27%
Net Income Growth Quarters	23%
Net Income Growth Years	7%
Net Income Growth3 Y	30.08%
Net Income Growth5 Y	42.18%
Pretax Margin	36.27%
Profit Margin	31.83%
Profit Per Employee	CNY 278,038
Profitable Years	9
ROA	17.96
Roa5y	13.13
ROCE	30.78
ROE	29.72
Roe5y	24.35
ROIC	48.48
Roic5y	49.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.77%
Cagr3y	11.19%
Cagr5y	13.57%
Div CAGR3	30.65%
EPS Growth	20.97
EPS Growth Q	25.39
EPS Growth Quarters	17
EPS Growth Years	7
EPS Growth3 Y	30.26
EPS Growth5 Y	35.23
FCF Growth	235.96%
FCF Growth Q	18.79%
FCF Growth3 Y	38.1%
FCF Growth5 Y	38.32%
OCF Growth	24.87%
OCF Growth Q	15.32%
OCF Growth3 Y	33.53%
OCF Growth5 Y	37.81%
Revenue Growth	25.24x
Revenue Growth Q	24.78x
Revenue Growth Quarters	23x
Revenue Growth Years	8x
Revenue Growth3 Y	27.95x
Revenue Growth5 Y	36.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.83
Assets	CNY 3.4B
Cash	CNY 1.3B
Current Assets	CNY 1.9B
Current Liabilities	CNY 361.9M
Debt	CNY 14.5M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.02
Equity	CNY 3B
Interest Coverage	1,158.8
Liabilities	CNY 423.4M
Long Term Assets	CNY 1.5B
Long Term Liabilities	CNY 61.5M
Net Cash	CNY 1.3B
Net Cash By Market Cap	CNY 3.9
Net Cash Growth	7.82%
Net Debt EBITDA	CNY -1.21
Net Debt Equity	CNY -0.42
Net Debt FCF	CNY -1.82
Tangible Book Value	CNY 2.5B
Tangible Book Value Per Share	CNY 18.11
WACC	2.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.2
Inventory Turnover	1.67
Net Working Capital	CNY 237.6M
Quick ratio	3.74
Working Capital	CNY 1.5B
Working Capital Turnover	CNY 1.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.07%
Dividend Growth	26.88%
Dividend Growth Years	5%
Dividend per share	CNY 1
Dividend Years	5
Dividend Yield	0.43%
Ex Div Date	2026-05-14
Last Dividend	CNY 1.75
Payout Frequency	Annual
Payout Ratio	19.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.75%
200-day SMA	266.8
3Y total return	37.46%
50-day SMA	242.6
50-day SMA vs 200-day SMA	50under200
5Y total return	88.89%
All Time High	337.2
All Time High Change	-31.02%
All Time High Date	2025-10-24
All Time Low	67.05
All Time Low Change	246.93%
All Time Low Date	2022-04-27
ATR	7.44
Beta	-0.35
Beta1y	0.21
Beta2y	0.17
Ch YTD	-4.38
High	235.8
High52	337.2
High52 Date	2025-10-24
High52ch	-31.02%
Low	230.2
Low52	219.5
Low52 Date	2026-03-23
Low52ch	5.98%
Ma50ch	-4.12%
Price vs 200-day SMA	-12.81%
RSI	32
RSI Monthly	47.77
RSI Weekly	41.96
Sharpe ratio	-0.69x
Sortino ratio	-0.84
Total Return	0.36%
Tr YTD	-4.38
Tr1m	-9.59%
Tr1w	-0.76%
Tr3m	1.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 944.5M
Operating Income Growth	22.64
Operating Income Growth Q	27.19
Operating Income Growth3 Y	31.73
Operating Income Growth5 Y	46.5
Operating margin	34.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	75,043,757%
Net Borrowing	3,981,695
Shares Insiders	20.03%
Shares Institutions	33.8%
Shares Out	140,638,803
Shares Qo Q	-0.83%
Shares Yo Y	0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 702.3M
Average Volume	1,014,620.65x
Bv Per Share	21.22
CAPEX	CNY -291M
Ch1m	-9.59
Ch1w	-0.76
Ch1y	-18.11
Ch3m	1.14
Ch3y	35.7
Ch5y	85.16
Ch6m	-17.95
Change	-0.85%
Change From Open	-1
Close	234.6
Days Gap	0.15
Depreciation Amortization	106,246,125
Dollar Volume	273,197,188.5
Earnings Date	2026-04-24
EBIT	CNY 944.5M
EBITDA	CNY 1.1B
EPS	CNY 6.13
F Score	7
FCF	CNY 702.3M
FCF EV Yield	2.23x
FCF Per Share	CNY 4.99
Financing CF	-627,561,239
Fiscal Year End	December
Founded	2,002
Goodwill	48,133,117
Graham Number	54.09647
Graham Upside	-76.74
Income Tax	CNY 134.6M
Investing CF	-575,340,398
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2025-06-19
Last Split Type	Forward
Lynch Fair Value	CNY 153
Lynch Upside	-34.13
Ma150	258.1
Ma150ch	-9.87%
Ma20	249.9
Ma20ch	-6.92%
Net CF	-221,074,536
Next Earnings Date	2026-08-21
Open	235
P FCF Ratio	46.58
P OCF Ratio	32.93
Payment Date	2025-06-19
Position In Range	43.09
Ppne	863,305,099
Price Date	2026-05-08
Price EBITDA	CNY 31.13
Ptbv Ratio	12.91
Relative Volume	1.17x
Revenue	2,723,728,946x
Tax By Revenue	4.94x
Tax Rate	13.63%
Tr6m	-17.95%
Volume	1,174,486
Z Score	57.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688617 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$1.00 annual per share

Payout ratio

+19.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

5 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2026-05-14

Performance

SHA/688617 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688617?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.8%

Share of float held by funds and institutions

Insider ownership

+20.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

SHA/688617 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.0

Neutral momentum band

Price vs 200-day MA

-12.8%

50/200-day relationship not available

Beta (5Y)

-0.35

Less volatile than the market

Sharpe ratio

-0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688617

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688617 stock rating?

sha/688617 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688617 analysis?

The full report lives at /stocks/sha/688617/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688617?

The latest report frames sha/688617 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688617 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.